Insider · CIK 0001859698
Kevin Ali
ceoofficerdirector
Files at OGN (Organon & Co.). First filing May 6, 2025, latest May 6, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$299k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OGN: Organon & Co.
OGNOct 9, 2026 · close 13.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | Organon & Co. | $299k 34,000 shares | +14% | 0% from low-57% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 5, 2025 | OGN Organon & Co. | POpen-market purchase Common Stock | +34,000 | $8.81 | $299k | 282,731 | May 6, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +48,758 | $0.00 | $0 | 248,677 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -26,964 | $14.51 | $391k | 221,713 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +38,974 | $0.00 | $0 | 260,687 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -21,553 | $14.51 | $313k | 239,134 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +21,472 | $0.00 | $0 | 260,606 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -11,875 | $14.51 | $172k | 248,731 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Stock Option (right to buy)derivative | +1,072,607 | $0.00 | $0 | 1,072,607 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +218,267 | $0.00 | $0 | 218,267 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -48,758 | $0.00 | $0 | 97,518 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -38,974 | $0.00 | $0 | 38,974 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -21,472 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Feb 20, 2025 | OGN Organon & Co. | AGrant or award Common Stock | +84,222 | $0.00 | $0 | 229,110 | Feb 24, 2025 |
| Feb 20, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -46,575 | $14.92 | $695k | 182,535 | Feb 24, 2025 |
| Feb 20, 2025 | OGN Organon & Co. | AGrant or award Common Stock | +15,423 | $0.00 | $0 | 197,958 | Feb 24, 2025 |
| Feb 20, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -8,529 | $15.29 | $130k | 199,919 | Feb 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.